Archives: 2026-04-13

Naturally occurring molecule rivals Ozempic in weight loss, sidesteps side effects

A Stanford Medicine study taps artificial intelligence to find a naturally occurring molecule called a peptide that suppressed appetite and led to weight loss in mice and pigs. Anaturally occurring molecule identified by Stanford Medicine researchers appears similar to semaglutide — also known as Ozempic — in suppressing appetite and reducing body weight. Notably, testing

Read More


Phase I trial published in Nature: China’s novel base-editing therapy brings hope of cure for thalassemia patients

In a breakthrough for gene therapy, the international academic journal Nature has published a landmark clinical study detailing the successful use of a novel base-editing drug to treat β-thalassemia. Jointly conducted by ShanghaiTech University, the First Affiliated Hospital of Guangxi Medical University, Fudan University, and CorrectSequence Therapeutics, the early-stage clinical trial of the base-editing drug CS-101 injection reports that

Read More


Designing a better treatment for solid tumor cancers that works ‘off-the-shelf’

Gene edits could solve obstacles to treatment for the most common types of cancer Since 2017, a personalized immunotherapy called Chimeric Antigen Receptor, or CAR-T cell treatment, has worked wonders to treat patients with blood cancers such as leukemia.  But when it comes to treating solid tumor cancers, such as lung, breast and kidney cancers

Read More


Colorectal Cancer and Mortality Risk Among Older Adults With vs Without Adenoma on Prior Colonoscopy

Study finds deaths from other causes far surpass colorectal cancer diagnosis, death Key Takeaways While older adults with adenoma at a prior colonoscopy were more likely to be diagnosed with and die from colorectal cancer (CRC) compared with those without adenoma, the cumulative incidence was low and dwarfed by that of death from other causes,

Read More


Discontinuation of Levothyroxine in Adults Aged 60 Years or Older

Experts call for better guidance on levothyroxine initiation, deprescribing Key Takeaways A quarter of older adults on hypothyroidism medication were able to wean off of it while maintaining adequate thyroid function, an open-label prospective study showed. In patients 60 and up, a protocol for stepwise reduction in levothyroxine led to 25.7% successfully discontinuing the medication

Read More


Researchers Identify Molecular “Brake” That Limits Axonal Regeneration After Injury to Nerves or Spinal Cord

New findings suggest blocking a key sensor protein could help neurons repair damaged connections Researchers from the Icahn School of Medicine at Mount Sinai have discovered a molecular switch in neurons that limits the regrowth of damaged axonal fibers. The findings, published in the journal Nature, show that blocking a protein called the aryl hydrocarbon receptor (AHR) may

Read More